Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells

Kettunen K, Boström PJ, Lamminen T, Heinosalo T, West G, Saarinen I, Kaipio K, Rantala J, Albanese C, Poutanen M, Taimen P

Eur Urol (2019)

Published on December 2, 2025

DOI: https://doi.org/10.1016/j.eururo.2019.06.016

← Back to Publications
O. Parilova et al. • 2026 • Nucleic Acids Research
Abstract RNA polymerase I (Pol I) synthesizes precursor ribosomal RNA, a key step in ribosome biogenesis. Elevated Pol I activity...
M. Gluud et al. • 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...
G. Follain et al. • 2026 • The EMBO Journal
Abstract The rapid, transient, and unpredictable nature of interactions between circulating cells and the endothelium challenges the investigation of these...